KUVAN 100 MG Oral Tablet
- RxCUI
- 1486691
- RxNorm name
- KUVAN 100 MG Oral Tablet
- Display name
- KUVAN 100 MG Oral Tablet
- Full name
- KUVAN 100 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kuvan | SAPROPTERIN DIHYDROCHLORIDE | BioMarin Pharmaceutical Inc. | af38711e-8873-4790-a92d-4d583e23fb89 | 2024-08-26 | Warnings, Adverse reactions | 1486691 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| af38711e-8873-4790-a92d-4d583e23fb89 | KUVAN 100 MG Oral Tablet | PSN | 79 | These highlights do not include all the information needed to use KUVAN safely and effectively. See full prescribing information for KUVAN. KUVAN (sapropterin dihydrochloride) tablets, for oral use KUVAN (sapropterin dihydrochloride) powder, for oral solution Initial U.S. Approval: 2007 | 20240826 |
| af38711e-8873-4790-a92d-4d583e23fb89 | sapropterin dihydrochloride 100 MG Oral Tablet [Kuvan] | SBD | 79 | These highlights do not include all the information needed to use KUVAN safely and effectively. See full prescribing information for KUVAN. KUVAN (sapropterin dihydrochloride) tablets, for oral use KUVAN (sapropterin dihydrochloride) powder, for oral solution Initial U.S. Approval: 2007 | 20240826 |
| af38711e-8873-4790-a92d-4d583e23fb89 | Kuvan 100 MG Oral Tablet | SY | 79 | These highlights do not include all the information needed to use KUVAN safely and effectively. See full prescribing information for KUVAN. KUVAN (sapropterin dihydrochloride) tablets, for oral use KUVAN (sapropterin dihydrochloride) powder, for oral solution Initial U.S. Approval: 2007 | 20240826 |